Journal article

Quantitative measurements of relative fluid-attenuated inversion recovery (FLAIR) signal intensities in acute stroke for the prediction of time from symptom onset

Bastian Cheng, Mathias Brinkmann, Nils D Forkert, Andras Treszl, Martin Ebinger, Martin Koehrmann, Ona Wu, Dong-Wha Kang, David S Liebeskind, Thomas Tourdias, Oliver C Singer, Soren Christensen, Marie Luby, Steven Warach, Jens Fiehler, Jochen B Fiebach, Christian Gerloff, Goetz Thomalla

Journal of Cerebral Blood Flow and Metabolism | SAGE PUBLICATIONS INC | Published : 2013

University of Melbourne Researchers

Grants

Awarded by National Institutes of Health


Awarded by Else Kroner-Fresenius-Stiftung


Awarded by Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin


Awarded by European Union


Funding Acknowledgements

Jochen B Fiebach has received fees as a board member, consultant, or lecturer from Boehringer Ingelheim, Lundbeck, Siemens, Syngis, and Synarc. Christian Gerloff has received fees as a consultant or lecture fees from Bayer Vital, Boehringer Ingelheim, EBS technologies, Glaxo Smith Kline, Lundbeck, Pfizer, Sanofi Aventis, Silk Road Medical, and UCB. David S Liebeskind has received fees as a consultant for CoAxia and Concentric Medical. A Gregory Sorensen was supported by grants from the National Institutes of Health and has received fees as a board member, consultant, or lecturer from ACRIN, Biogen, Genzyme, Mitsubishi, and has received royalties from GE and Olea. Gotz Thomalla has received a research grant from the Else Kroner-Fresenius-Stiftung. Thomas Tourdias has received a national grant from the French Government (PHRC). Ona Wu was supported in part by grants from the National Institutes of Health (R01NS059775, R01NS063925, and P50NS051343) and has received royalties and licensing fees from GE, Olea, and Imaging Biometrics. The other authors report no conflict of interest.PRE-FLAIR has received funding from the Else Kroner-Fresenius-Stiftung (2009_A36). In Berlin, data were collected within the 1,000+ study, which has received funding from the Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin (01 EO 0801). EPITHET was a phase II prospective, randomized, double-blinded, placebo-controlled, multinational trial funded by the National Health and Medical Research Council (Australia), the National Stroke Foundation (Australia), and the Heart Foundation of Australia. VIRAGE is a national multicenter study supported by French national grant PHRC.This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS), and also by the European Union's Seventh Framework Programme grant agreement No. 202213 and No. 223153 (European Stroke Network), the Volkswagen Foundation, and the Deutsche Forschungsgemeinschaft.